Smith Manion, MD
Pain Medicine · Shawnee Mission, KSNPI 1538379656
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $40,750 of the $55,010 with a category attached, or 74.1%. MML US, Inc. accounts for 97.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2021 at $30,876 and has fallen 98.0% since, to $623 in 2025.
Across 97 payments — averaging $567.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MML US, Inc.$54K
- Saluda Medical Americas, Inc.$658
- Nevro Corp.$230
- Boston Scientific$117
- Abbott$106
- Globus Medical$102
- plus $273 from 9 others
Across 51 payments — averaging $4377.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- MML US, Inc.$223K
What the payments were for
- Consulting fees$5,0509%
- Speaking & faculty fees$40,75074%
- Travel & lodging$7,27913%
- Food & beverage$1,9314%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| MML US, Inc. | 40 | $53,526 |
| Saluda Medical Americas, Inc. | 20 | $658 |
| Nevro Corp. | 11 | $230 |
| Boston Scientific | 7 | $117 |
| Abbott | 4 | $106 |
| Globus Medical | 3 | $102 |
| Medtronic | 3 | $68 |
| GRT US Holding, Inc. | 2 | $39 |
| Averitas Pharma Inc. | 1 | $39 |
| Spinal Simplicity, LLC | 1 | $33 |
| BD | 1 | $32 |
| Biotronik NRO, Inc. | 1 | $19 |
| Zimmer Biomet | 1 | $15 |
| Trevena, Inc. | 1 | $14 |
| Stimwave Technologies Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ReActiv8$53,020
How this compares
$55,010 in reported general payments places this provider in the 85th percentile of 64 pain medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 20 | $683 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $222 |
| Oxycodone Hcl | 22 | $218 |
| Tizanidine Hcl | 24 | $171 |
| Gabapentin | 15 | $120 |
| Meloxicam | 17 | $42 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Shawnee Mission
- Haley WardripShawnee Mission$14K
- Usman LatifKansas City$734K
- Dawood SayedKansas City$649K
- Andrea ChadwickKansas City$269K
- Mayank GuptaOverland Park$199K
- Brian GoentzelWichita$99K
- Brian KimOverland Park$61K
- Jeffrey FosterOverland Park$56K
- Ryan ZwickMerriam$32K
- Christopher LamKansas City$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.